Lipopeptide-based liposomes for DNA delivery into cells expressing neuropilin-1

References

• Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: Problems and prospects of active and tumor specific drug release. Prog Lipid Res 2005; 44: 68–97
   PubMed Web of Science ®Google Scholar
• Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998; 279: 377–380
   PubMed Web of Science ®Google Scholar
• Babu JS, Nair S, Kanda P, Rouse BT. Priming for virus-specific CD8+ but not CD4+ cytotoxic T lymphocytes with synthetic lipopeptide is influenced by acylation units and liposome encapsulation. Vaccine 1995; 13: 1669–1676
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Crago A, Chung JJ, Wendt MA, Shaw LM, Robinso J, Mercurio AM. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61: 5736–5740
   PubMed Web of Science ®Google Scholar
• Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner P. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994; 269: 2550–2561
   PubMed Web of Science ®Google Scholar
• Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29(6 Suppl. 16)15–18
   PubMed Web of Science ®Google Scholar
• de Groot FM, Broxterman HJ, Adams HP, van Vliet A, Tesser GI, Elderkamp YW, Schraa AJ, Kok RJ, Molema G, Pinedo HM, Scheeren HW. Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug. Mol Cancer Ther 2002; 1: 901–911
   PubMed Web of Science ®Google Scholar
• Janssen AP, Schiffellers RM, ten Hagen TLM, Koning GA, Schraa AJ, Kok RJ, Storm G, Molema G. Peptide-targed PEG-liposome in anti-angiogenic therapy. Int J Pharm 2003; 254: 55–58
   PubMed Web of Science ®Google Scholar
• Lee RJ, Huang L. Lipid vector systems for gene transfer. Crit Rev Ther Drug 1997; 14: 173–206
   PubMed Web of Science ®Google Scholar
• Lesage D, Cao A, Briane D, Lievre N, Coudert R, Raphael M, Salzmann JL, Taillandier E. Evaluation of in vitro transfection of gliosarcoma 9L cells using cationic liposomes derived from cholesterol. Biochim Biophys Acta 2002; 1564: 393–402
   PubMed Web of Science ®Google Scholar
• Liang MT, Davies NM, Toth I. Encapsulation of lipopeptides within liposomes: Effect of number of lipid chains, chain length and method of liposome preparation. Int J Pharm 2005; 301: 247–254
   PubMed Web of Science ®Google Scholar
• Marcucci F, Lefoulon F. Active targeting with paniculate drug carriers in tumor therapy: Damentals and recent progress. Drug Discov Today 2004; 9: 219–228
   PubMed Web of Science ®Google Scholar
• Nabel GJ, Gordon D, Bishop D, Nickoloff BJ, Yang ZY, Aruga A, Cameron MJ, Nabel EG, Chang AE. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA 1996; 93: 15388–15393
   PubMed Web of Science ®Google Scholar
• Neufeld G, Cohen T, Shraga N. The neuropilins: Multifunctional semaphoring and VEGF receptor that modulate axon guidance and angiogenesis. Trends Cardiovasc Med 2002; 12: 13–19
   PubMed Web of Science ®Google Scholar
• Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997; 15: 542–546
   PubMed Web of Science ®Google Scholar
• Percot A, Briane D, Coudert R, Reynier P, Bouchemal N, Lièvre N, Hantz E, Salzmann JL, Cao A. A Hydroxyethylated Cholesterol-based cationic lipid for DNA Delivery: Effect of conditioning. Int J Pharm 2004; 278: 143–163
   PubMed Web of Science ®Google Scholar
• Perret GY, Starzec A, Hauet, Vergote J, Lepecheur M, Vassy R, Leger G, Verbeke KA, Bormans G, Nicolas P, Verbruggen AM, Moretti JL. In vitro evaluation and biodistribution of a 99mTc-labelled anti-VEGF peptide targeting neuropilin-1. Nucl Med Biol 2004; 31: 575–581
   PubMed Web of Science ®Google Scholar
• Reynier P, Briane D, Coudert R, Fadda G, Bouchemal N, Bissieres P, Taillandier E, Cao A. Modifications in the head group and in the spacer of cholesterol-based cationic lipids promote transfection in melanoma B16-F10 cells and tumours. J Drug Target 2004; 58: 25–38
   Google Scholar
• Rolland AP. From genes to gene medicines: Recent advances in nonviral gene delivery. Crit Rev Ther Drug 1998; 15: 143–198
   PubMed Web of Science ®Google Scholar
• Schatzlein AG. Non-viral vectors in cancer gene therapy: Principles and progress. Anticancer Drug 2001; 12: 275–304
   Google Scholar
• Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G. Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J Control Release 2003; 91: 115–122
   PubMed Web of Science ®Google Scholar
• Shadidi M, Sioud M. Selective targeting of cancer cells using synthetic peptides. Drug Resist Updat 2003a; 6: 363–371
   PubMed Web of Science ®Google Scholar
• Shadidi M, Sioud M. Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells. FASEB J 2003b; 17: 256–258
   PubMedGoogle Scholar
• Starzec A, Vassy R, Hamma-Kourbali Y, Perret G. Heptapeptide A7R competes for VEGF165 binding to neuropilin-1 but not to VEGF2/KDR. First interdisciplinary conference on angiogenesis. 2001, Paris, October 6–9
   Google Scholar
• Tirand L, Frochot C, Vanderesse R, Thomas N, Trinquet E, Pinel S, Viriot ML, Guillemin F, Barberi-Heyob M. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photoensitizer and potentiates its photodynamic activity in human endothelial cells. J Control Release 2006; 111: 153–164
   PubMed Web of Science ®Google Scholar
• Yang JP, Huang L. Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther 1997; 4: 950–960
   PubMed Web of Science ®Google Scholar
• Zabner J. Cationic lipids used in gene transfer. Adv Drug Deliv Rev 1997; 27: 17–28
   PubMed Web of Science ®Google Scholar